Nobel Laureate’s licensing spat underscores the importance of patent support in universities

Lack of IP funds and staff at Kyoto University may have left immunotherapy pioneer Tasuku Honjo with a poor deal in agreement with Ono Pharmaceutical.


Get unlimited access to all IAM content